Goldman Sachs Community Municipal Bond ETF (GMUN) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GMUN Stock Alerts $49.32 -0.02 (-0.04%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsOwnershipStock AnalysisChartDividendHoldingsOwnership Goldman Sachs Community Municipal Bond ETF Stock Price Performance5 Day Performance-0.24%1 Month Performance-1.24%3 Month Performance-1.62%6 Month Performance+1.94%Year-To-Date Performance-2.72%1 Year Performance-2.43% Receive GMUN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Goldman Sachs Community Municipal Bond ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> GMUN Stock Chart for Saturday, April, 27, 2024 GMUN Chart by TradingView Goldman Sachs Community Municipal Bond ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$49.44$49.40-0.08%$49.40$49.404 shs$9.88 million04/23/2024$49.44$49.44$49.44$49.441 shs$9.89 million04/22/2024$49.44$49.44$49.44$49.441 shs$9.89 million04/19/2024$49.42$49.44+0.04%$49.44$49.44320 shs$19.78 million04/18/2024$49.45$49.42-0.06%$49.45$49.42320 shs$19.77 million04/17/2024$49.38$49.45+0.14%$49.45$49.451 shs$19.78 million Get the Latest News and Ratings for GMUN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Goldman Sachs Community Municipal Bond ETF and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$49.43$49.38-0.10%$49.38$49.38500 shs$19.75 million04/15/2024$49.47$49.43-0.08%$49.43$49.43120 shs$19.77 million04/12/2024$49.37$49.47+0.20%$49.47$49.472 shs$19.79 million04/11/2024$49.31$49.37+0.12%$49.37$49.28132 shs$19.75 million04/10/2024$49.63$49.31-0.64%$49.35$49.31601 shs$19.72 million04/09/2024$49.55$49.63+0.16%$49.66$49.611,205 shs$19.85 million04/08/2024$49.50$49.55+0.10%$49.55$49.52781 shs$19.82 million04/05/2024$49.61$49.50-0.21%$49.50$49.501 shs$19.80 million04/04/2024$49.56$49.61+0.09%$49.61$49.613 shs$19.84 million04/03/2024$49.61$49.56-0.10%$49.61$49.565,192 shs$19.82 million04/02/2024$49.70$49.61-0.18%$49.61$49.611 shs$19.84 million04/01/2024$49.88$49.70-0.36%$49.70$49.701 shs$19.88 million03/29/2024$49.88$49.88$49.88$49.884 shs$19.95 million03/28/2024$49.90$49.88-0.04%$49.88$49.884 shs$19.95 million03/27/2024$49.94$49.90-0.08%$49.90$49.901,203 shs$19.96 million03/26/2024$49.98$49.94-0.08%$49.94$49.911,203 shs$19.98 million03/25/2024$50.05$49.98-0.13%$49.98$49.981 shs$19.99 million03/22/2024$49.97$50.04+0.14%$50.04$50.044 shs$20.02 million03/21/2024$50.01$49.97-0.08%$49.97$49.971 shs$19.99 million03/20/2024$50.03$50.01-0.04%$50.01$50.011 shs$20.00 million03/19/2024$50.01$50.03+0.04%$50.03$50.031 shs$20.01 million03/18/2024$49.99$50.01+0.04%$50.01$50.015 shs$20.00 million03/15/2024$50.01$49.99-0.04%$49.99$49.94387 shs$20.00 million03/14/2024$50.12$50.01-0.22%$50.01$50.01759 shs$20.00 million03/13/2024$50.07$50.12+0.10%$50.13$50.12759 shs$20.05 million03/12/2024$50.10$50.07-0.06%$50.07$50.073 shs$20.03 million03/11/2024$50.14$50.10-0.07%$50.10$50.1015 shs$20.04 million03/08/2024$50.12$50.13+0.02%$50.13$50.134 shs$20.05 million03/07/2024$50.05$50.12+0.14%$50.12$50.121 shs$20.05 million03/06/2024$50.06$50.05-0.02%$50.05$50.051 shs$20.02 million03/05/2024$49.97$50.06+0.18%$50.06$50.061 shs$20.02 million03/04/2024$50.04$49.97-0.14%$49.97$49.972 shs$19.99 million03/01/2024$50.15$50.04-0.22%$50.04$50.04400 shs$20.02 million02/29/2024$50.10$50.15+0.10%$50.15$50.15102 shs$20.06 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024$50.06$50.10+0.08%$50.10$50.102 shs$20.04 million02/27/2024$50.06$50.06$50.06$50.061 shs$20.02 million02/26/2024$50.11$50.06-0.10%$50.06$50.06100 shs$20.02 million02/23/2024$50.03$50.11+0.16%$50.11$50.111 shs$20.04 million02/22/2024$50.01$50.03+0.04%$50.03$50.032 shs$20.01 million02/21/2024$50.01$50.01$50.01$50.012 shs$20.00 million02/20/2024$49.97$50.01+0.08%$50.01$50.012 shs$20.00 million02/16/2024$50.03$49.97-0.12%$49.97$49.9728 shs$19.99 million02/15/2024$49.99$50.03+0.08%$50.03$50.0328 shs$20.01 million02/14/2024$49.87$49.99+0.24%$49.99$49.9928 shs$20.00 million02/13/2024$50.06$49.87-0.38%$49.87$49.871 shs$19.95 million02/12/2024$50.00$50.06+0.12%$50.06$50.06100 shs$20.02 million02/09/2024$49.99$50.00+0.02%$50.00$50.001 shs$20 million02/08/2024$49.98$49.99+0.02%$49.99$49.9928 shs$20.00 million02/07/2024$50.02$49.98-0.08%$49.98$49.95600 shs$19.99 million02/06/2024$49.95$50.02+0.14%$50.02$50.022 shs$20.01 million02/05/2024$50.11$49.95-0.32%$49.95$49.9549 shs$19.98 million02/02/2024$50.31$50.11-0.40%$50.11$50.11301 shs$20.04 million02/01/2024$50.43$50.31-0.24%$50.31$50.23301 shs$20.12 million01/31/2024$50.27$50.43+0.32%$50.43$50.431 shs$20.17 million01/30/2024$50.26$50.27+0.02%$50.27$50.2748 shs$20.11 million01/29/2024$50.13$50.26+0.25%$50.26$50.261 shs$20.10 million01/26/2024$50.36$50.13-0.46%$50.13$50.131 shs$20.05 million01/25/2024$50.24$50.36+0.24%$50.36$50.361 shs$20.14 million Related Companies: X-Square Municipal Income Tax Free ETF Stock Chart First Trust New York Municipal High Income ETF Stock Chart BlackRock Intermediate Muni Income Bond ETF Stock Chart AB Tax-Aware Intermediate Municipal ETF Stock Chart AB Tax-Aware Long Municipal ETF Stock Chart Macquarie Tax-Free USA Short Term ETF Stock Chart BlackRock Short-Term California Muni Bond ETF Stock Chart Eaton Vance Intermediate Municipal Income ETF Stock Chart John Hancock Dynamic Municipal Bond ETF Stock Chart IQ MacKay California Municipal Intermediate ETF Stock Chart Receive GMUN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Goldman Sachs Community Municipal Bond ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:GMUN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Community Municipal Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.